Eli Lilly to buy Avid for $300mm up front plus earn-outs
- Radiopharmaceuticals, Contrast Agents
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.